24/7 Market News Snapshot 13 May, 2025 – Vaxart, Inc Common Stock (NASDAQ:VXRT)

May 13, 2025

DENVER, Colo., 13 May, 2025 (www.247marketnews.com) – (NASDAQ:VXRT) are discussed in this article.
Vaxart, Inc. (VXRT) commenced trading today at $0.41, reflecting a notable bullish momentum with an increase of approximately 6.67%. Currently, the stock is trading at $0.432, suggesting some profit-taking after the initial surge. A trading volume of 5.25 million shares indicates robust investor engagement and interest in the company. Investors should closely observe key support levels beginning with the opening price, while resistance appears to be around $0.45. Although technical indicators hint at a possible upward trend, ongoing volatility remains a concern. Market sentiment and developments related to Vaxart’s vaccine pipeline may act as important price catalysts moving forward.

In a significant development, Vaxart has announced the appointment of Jeroen Grasman as its new Chief Financial Officer (CFO), effective May 19, 2025. Grasman’s extensive experience spanning over two decades in the biotechnology sector positions him to contribute significantly as Vaxart continues to innovate in the area of oral vaccinations. He succeeds Phillip Lee, who will transition to a non-executive role until June 1, 2025.

CEO Steven Lo expressed confidence in Grasman’s capabilities, stating that his financial expertise and proven success will be pivotal as the company accelerates its oral vaccine programs. Prior to joining Vaxart, Grasman held the CFO position at AltruBio and had significant roles at PACT Pharma and Genentech. He earned a Master’s degree in Applied Mathematics from Groningen University and an MBA from Harvard Business School.

Grasman remarked on his enthusiasm about joining Vaxart, emphasizing the innovative potential of the company’s oral vaccination platform. Vaxart is at the forefront of developing oral recombinant vaccines aimed at simplifying immunization processes, and Grasman’s leadership is anticipated to foster continued progress in the company’s strategic initiatives.

Related news for (VXRT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.